Cargando…
Preliminary Structural Elucidation of β-(1,3)-glucan Synthase from Candida glabrata Using Cryo-Electron Tomography
Echinocandin drugs have become a front-line therapy against Candida spp. infections due to the increased incidence of infections by species with elevated azole resistance, such as Candida glabrata. Echinocandins target the fungal-specific enzyme ß-(1,3)-glucan synthase (GS), which is located in the...
Autores principales: | Jiménez-Ortigosa, Cristina, Jiang, Jennifer, Chen, Muyuan, Kuang, Xuyuan, Healey, Kelley R., Castellano, Paul, Boparai, Nikpreet, Ludtke, Steven J., Perlin, David S., Dai, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914498/ https://www.ncbi.nlm.nih.gov/pubmed/33562124 http://dx.doi.org/10.3390/jof7020120 |
Ejemplares similares
-
Genetic Drivers of Multidrug Resistance in Candida glabrata
por: Healey, Kelley R., et al.
Publicado: (2016) -
Fungal Resistance to Echinocandins and the MDR Phenomenon in Candida glabrata
por: Healey, Kelley R., et al.
Publicado: (2018) -
Differential Regulation of Echinocandin Targets Fks1 and Fks2 in Candida glabrata by the Post-Transcriptional Regulator Ssd1
por: Healey, Kelley R., et al.
Publicado: (2020) -
The Gastrointestinal Tract Is a Major Source of Echinocandin Drug Resistance in a Candida glabrata Colonization Mouse Model
por: Healey, Kelley, et al.
Publicado: (2017) -
Histone Acetylation Regulator Gcn5 Mediates Drug Resistance and Virulence of Candida glabrata
por: Yu, Shuying, et al.
Publicado: (2022)